Furthermore, immunohistochemistry staining with the IDH1 mutant enzyme antibody IDH1‐R132H indicated that Au‐R12P effectively differentiates between IDH1‐WT and IDH1‐MUT gliomas allografts. The gene discussed is IDH1; the disease is central nervous system cancer.